World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
15173
World Ranking
14228
National Ranking
1114

Andrea Pellagatti publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Andrea Pellagatti sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 215 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Andrea Pellagatti D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Pellagatti sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Andrea Pellagatti is affiliated with the University of Oxford in the United Kingdom. Their research spans across multiple disciplines, primarily within medicine and biochemistry, genetics, and molecular biology.

The scientist has contributed extensively to the fields of hematology, molecular biology, genetics, immunology, and cancer research. Their main research topics include acute myeloid leukemia research, RNA research and splicing, myeloproliferative neoplasms diagnosis and treatment, blood disorders and treatments, RNA modifications and cancer, epigenetics and DNA methylation, and protein degradation and inhibitors.

Andrea Pellagatti has a strong publication record in several journals, among which the most frequent include:

  • Blood
  • Advances in Biological Regulation
  • Nature Medicine
  • eLife
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent papers exemplify ongoing research interests and contributions, including the following:

  • "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes" (2022), published in NEJM Evidence
  • "Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes" (2020), published in Nature Medicine
  • "SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS" (2020), published in Blood
  • "SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications" (2020), published in Leukemia
  • "Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations" (2022), published in eLife

Collaborations appear to be an integral part of their research. Frequent co-authors include:

  • Jacqueline Boultwood
  • Matilde Y. Follo
  • Carlo Finelli
  • Pierre Fenaux
  • Peter L. Greenberg

Best Publications

  • Clinical and biological implications of driver mutations in myelodysplastic syndromes.

    Elli Papaemmanuil;Moritz Gerstung;Luca Malcovati;Sudhir Tauro

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  • Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Petter S. Woll;Una Kjällquist;Onima Chowdhury;Helen Doolittle

  • Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients

    Andrea Pellagatti;Martin Jädersten;Ann-Mari Forsblom;Helen Cattan

  • Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

    A Pellagatti;M Cazzola;A Giagounidis;J Perry

  • Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

    J Boultwood;J Perry;A Pellagatti;M Fernandez-Mercado

  • Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

    Andrea Pellagatti;Mario Cazzola;Aristoteles A N Giagounidis;Luca Malcovati

  • Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes

    Moritz Gerstung;Andrea Pellagatti;Luca Malcovati;Aristoteles Giagounidis

  • Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.

    Britta Will;Li Zhou;Thomas O. Vogler;Susanna Ben-Neriah

  • Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

    Andrea Pellagatti;Richard N. Armstrong;Violetta Steeples;Eshita Sharma

  • TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    Detlef Haase;Kristen E Stevenson;Donna Neuberg;Jaroslaw P Maciejewski

  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    Luca Malcovati;Kristen Stevenson;Elli Papaemmanuil;Donna Neuberg

  • Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

    Laura Barreyro;Britta Will;Boris Bartholdy;Li Zhou

  • Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

    H. Dolatshad;A. Pellagatti;M. Fernandez-Mercado;B. H. Yip

  • U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.

    Molly A. Smith;Molly A. Smith;Gaurav S. Choudhary;Andrea Pellagatti;Kwangmin Choi

  • Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.

    Jacqueline Boultwood;Andrea Pellagatti;Helen Cattan;Charles H. Lawrie

  • Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS

    Li Zhou;Aaron N. Nguyen;Davendra Sohal;Jing Ying Ma

  • IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

    Carolina Schinke;Orsolya Giricz;Weijuan Li;Aditi Shastri

Frequent Co-Authors

Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Amit Verma
Amit Verma Albert Einstein College of Medicine
Mario Cazzola
Mario Cazzola University of Pavia
Ulrich Steidl
Ulrich Steidl Albert Einstein College of Medicine
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute
Alan F. List
Alan F. List Precision BioSciences
Paresh Vyas
Paresh Vyas University of Oxford
Seishi Ogawa
Seishi Ogawa Kyoto University
Amittha Wickrema
Amittha Wickrema University of Chicago
Elli Papaemmanuil
Elli Papaemmanuil Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens the door to a wide range of rewarding careers, and online education has made specialized pathways more accessible than ever. Students interested in health and nutrition may explore options like an accelerated nutrition degree online, which can fast-track their education and entry into the workforce.

For those already in nursing, advancing from RN to BSN can enhance skills and job prospects. RN to BSN online programs offer flexibility and support for working professionals. If you're considering leadership or administrative roles in healthcare, a fast online master's in healthcare management can jumpstart your journey.

For a career focused on mental health, online PMHNP programs train advanced practice nurses to support patients’ mental well-being. Online degrees provide versatility, making it easier than ever to customize your studies and career path within the health and science sectors.

Best Scientists Citing Andrea Pellagatti

Trending Scientists

Recently Published Articles